Delivery Order SPE2DB20D2002-SPE2DB22FL15K

Award Date 1/24/22
Potential Completion Date 1/25/22
Potential Value $2.4K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a pharmaceutical product, with a ceiling value of $3,745.24 and a period of performance ending on January 31, 2024. This contract was not set aside for any specific business classification. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award is for the delivery of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML pharmaceutical products to the Defense Logistics Agency (DLA). The $4,639.10 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has an ultimate completion date of February 5, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of TYPHIM VI 25 MCG/0.5 ML SYRNG 0.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract is a Delivery Order worth $3,295.92 with a period of performance through March 15, 2023. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the TYPHIM VI 25 MCG/0.5 ML VIAL 10ML medical product, with a ceiling value of $2,808.93 and an ultimate completion date of July 12, 2024. The contract vehicle is firm fixed price and is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical and medical supply distributor, for TYPHIM VI 25 MCG/0.5 ML VIAL 10ML. The contract has a ceiling value of $8,606.89 and runs through August 12, 2024. It is a firm fixed price contract with no set-aside designation. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to...
This federal contract award is for the delivery of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML vaccines to the Defense Logistics Agency (DLA). The $7,255.27 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has an ultimate completion date of November 27, 2023. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
This is a federal contract award to Amerisourcebergen Drug Corp, a division of Amerisourcebergen Corporation, for the delivery of the pharmaceutical product "TYPHIM VI 25 MCG/0.5 ML VIAL 10ML". The contract, awarded by the Defense Logistics Agency (DLA) Troop Support Medical, is a Delivery Order with a Firm Fixed Price of $7,114.87 and a completion date of April 17, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA, valued at up to...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,842.00, is for the delivery of TYPHIM VI 25 MCG/0.5 ML SYRNG 0.5ML, a vaccine product. The contract has a firm fixed price and an ultimate completion date of November 19, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award is for the delivery of TYPHIM VI 25 MCG/0.5 ML SYRNG 0.5ML vaccine to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for a ceiling value of $2,911.25. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is February 1, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a vaccine product. The contract has a ceiling value of $46,339.37 and a period of performance through January 22, 2024. The contract is a firm fixed-price arrangement with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...
  • SPE2DB20D2002
    Indefinite Delivery Contract
  • SPE2DB20D2002-SPE2DB22FL15K
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a pharmaceutical product. The contract has a ceiling value of $2,359.92 and an ultimate completion date of January 25, 2022.

Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The contract does not have a set-aside designation, indicating open competition. This contract award demonstrates Amerisourcebergen's role as a critical supplier of essential medical commodities to federal government agencies, particularly the Department of Defense and its military healthcare programs.

Generated 2/27/25, 12:10 PM